Diabetes National Research Group is located in Port Saint Lucie, FL. The organization was established in 2001. According to its NTEE Classification (G11) the organization is classified as: Single Organization Support, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Diabetes National Research Group is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 03/2021, Diabetes National Research Group generated $6.3k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 7 years, the organization has seen revenues fall by an average of (37.5%) each year. All expenses for the organization totaled $33.8k during the year ending 03/2021. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
DIABETES NATIONAL RESEARCH GROUP (DNRG) IS A NON- PROFIT PUBLIC BENEFIT CORPORATION AND IS NOT ORGANIZED FOR THE PRIVATE GAIN OF ANY PERSON. DNRG OPERATES FOR THE BENEFIT OF TORREY PINES INSTITUTE OF MOLECULAR STUDIES, INC., BY PROVIDING FINANCIAL
Describe the Organization's Program Activity:
Part 3 - Line 4a
IN TYPE 1 DIABETES, CELLS IN THE PANCREAS THAT PRODUCE INSULIN ARE "ATTACKED" BY THE BODY'S OWN T-CELLS. T-CELLS ARE THE BODY'S IMMUNE CELLS WHOSE JOB IT IS TO DESTROY INVADING ORGANISMS. BUT IN TYPE 1 DIABETES, THESE T-CELLS ALSO ATTACK THE BODY THAT THEY ARE SUPPOSED TO PROTECT. FUNDED BY THE NATIONAL INSTITUTES OF HEALTH AND THE DIABETES NATIONAL RESEARCH GROUP, SCIENTISTS IN SAN DIEGO ARE BEGINNING TO UNDERSTAND HOW THE PANCREATIC SELF-ANTIGENS (SUBSTANCES CAPABLE OF INDUCING AN IMMUNE RESPONSE)ARE PROCESSED AND PRESENTED. MANY GRANTING AGENCIES DO NOT PROVIDE SUFFICIENT FUNDS TO COVER UNEXPECTED EXPENSES, TO PURCHASE VITAL LABORATORY EQUIPMENT, OR TO SUPPORT SCIENTISTS' TRAVEL TO MEET WITH OTHERS IN THE FIELD. BY PROVIDING SUPPLEMENTAL GRANT FUNDS, THE DIABETES NATIONAL RESEARCH GROUP IS IN EFFECT WORKING IN PARTNERSHIP WITH OTHER GRANTING ORGANIZATIONS TO ENSURE THAT THIS IMPORTANT WORK CONTINUES. DURING THE PAST YEAR, DIABETES NATIONAL RESEARCH GROUP PROVIDED SUPPORT FOR THESE TYPES OF SUPPLEMENTAL OR "COST SHARING" PROGRAMS. DNRG AWARDED GRANTS FOR RESEARCH PROJECTS RELATED TO TYPE 1 AND TYPE 2 DIABETES. FUNDS WERE USED FOR NEW LABORATORY EQUIPMENT, LABORATORY SUPPLIES, SCIENTISTS' SALARIES, AND TRAVEL TO SCIENTIFIC MEETINGS. TRAVEL TO MEETINGS IS CRUCIAL IN ORDER TO ESTABLISH AND MAINTAIN COLLABORATIONS WITH OTHER SCIENTISTS THROUGHOUT THE WORLD, AND TO SHARE RESEARCH RESULTS. DNRG ALSO SUPPORTED PROGRAM ACTIVITIES THROUGHOUT THE YEAR INCLUDING DISTRIBUTION OF EDUCATIONAL MATERIALS AND ORAL PRESENTATIONS TO THE GENERAL PUBLIC. ACTIVITIES CONDUCTED BY DIABETES NATIONAL RESEARCH GROUP HAVE RESULTED IN AN ENORMOUS BENEFIT TO SCIENTISTS THROUGHOUT THE WORLD. OVER THE PAST FEW YEARS, PUBLICATIONS, ORAL PRESENTATIONS, COLLABORATIONS AND THE SHARING OF RESEARCH RESULTS WITH SCIENTISTS AND STUDENTS OCCURRED IN MANY COUNTRIES. AS A RESULT OF THIS SUPPORT WITHIN THE UNITED STATES, SCIENTISTS AND STUDENTS FROM AT LEAST HALF OF THE STATES HAVE BENEFITED BY ATTENDING LECTURES, READING JOURNAL ARTICLES, BEGINNING NEW RESEARCH COLLABORATIONS, AND MAINTAINING ESTABLISHED COLLABORATIVE EFFORTS.
IN TYPE 1 DIABETES, CELLS IN THE PANCREAS THAT PRODUCE INSULIN ARE "ATTACKED" BY THE BODY'S OWN T-CELLS. T-CELLS ARE THE BODY'S IMMUNE CELLS WHOSE JOB IT IS TO DESTROY INVADING ORGANISMS. BUT IN TYPE 1 DIABETES, THESE T-CELLS ALSO ATTACK THE BODY THAT THEY ARE SUPPOSED TO PROTECT. FUNDED BY THE NATIONAL INSTITUTES OF HEALTH AND THE DIABETES NATIONAL RESEARCH GROUP, SCIENTISTS IN SAN DIEGO ARE BEGINNING TO UNDERSTAND HOW THE PANCREATIC SELF-ANTIGENS (SUBSTANCES CAPABLE OF INDUCING AN IMMUNE RESPONSE)ARE PROCESSED AND PRESENTED. MANY GRANTING AGENCIES DO NOT PROVIDE SUFFICIENT FUNDS TO COVER UNEXPECTED EXPENSES, TO PURCHASE VITAL LABORATORY EQUIPMENT, OR TO SUPPORT SCIENTISTS' TRAVEL TO MEET WITH OTHERS IN THE FIELD. BY PROVIDING SUPPLEMENTAL GRANT FUNDS, THE DIABETES NATIONAL RESEARCH GROUP IS IN EFFECT WORKING IN PARTNERSHIP WITH OTHER GRANTING ORGANIZATIONS TO ENSURE THAT THIS IMPORTANT WORK CONTINUES. DURING THE PAST YEAR, DIABETES NATIONAL RESEARCH GROUP PROVIDED SUPPORT FOR THESE TYPES OF SUPPLEMENTAL OR "COST SHARING" PROGRAMS. DNRG AWARDED GRANTS FOR RESEARCH PROJECTS RELATED TO TYPE 1 AND TYPE 2 DIABETES. FUNDS WERE USED FOR NEW LABORATORY EQUIPMENT, LABORATORY SUPPLIES, SCIENTISTS' SALARIES, AND TRAVEL TO SCIENTIFIC MEETINGS. TRAVEL TO MEETINGS IS CRUCIAL IN ORDER TO ESTABLISH AND MAINTAIN COLLABORATIONS WITH OTHER SCIENTISTS THROUGHOUT THE WORLD, AND TO SHARE RESEARCH RESULTS. DNRG ALSO SUPPORTED PROGRAM ACTIVITIES THROUGHOUT THE YEAR INCLUDING DISTRIBUTION OF EDUCATIONAL MATERIALS AND ORAL PRESENTATIONS TO THE GENERAL PUBLIC. ACTIVITIES CONDUCTED BY DIABETES NATIONAL RESEARCH GROUP HAVE RESULTED IN AN ENORMOUS BENEFIT TO SCIENTISTS THROUGHOUT THE WORLD. OVER THE PAST FEW YEARS, PUBLICATIONS, ORAL PRESENTATIONS, COLLABORATIONS AND THE SHARING OF RESEARCH RESULTS WITH SCIENTISTS AND STUDENTS OCCURRED IN MANY COUNTRIES. AS A RESULT OF THIS SUPPORT WITHIN THE UNITED STATES, SCIENTISTS AND STUDENTS FROM AT LEAST HALF OF THE STATES HAVE BENEFITED BY ATTENDING LECTURES, READING JOURNAL ARTICLES, BEGINNING NEW RESEARCH COLLABORATIONS, AND MAINTAINING ESTABLISHED COLLABORATIVE EFFORTS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Pamela G Houghten Secretary | Officer | 1 | $0 |
George B Thornton Trustee | Trustee | 1 | $0 |
Richard A Houghten President/trustee | Trustee | 1 | $0 |
Patricia S Wu Trustee | Trustee | 1 | $0 |
Larry Pelton Trustee | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Total Revenue from Contributions, Gifts, Grants & Similar | $6,303 |
Investment income | $3 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $6,306 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $10,000 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $1,129 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $5,302 |
Advertising and promotion | $0 |
Office expenses | $389 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $0 |
Total functional expenses | $33,820 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $0 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Total liabilities and net assets/fund balances | $0 |
Over the last fiscal year, we have identified 1 grants that Diabetes National Research Group has recieved totaling $23,852.
Awarding Organization | Amount |
---|---|
Health First Americas Charities Chantilly, VA PURPOSE: GENERAL SUPPORT | $23,852 |
Organization Name | Assets | Revenue |
---|---|---|
The Bell Center For Early Intervention Programs Birmingham, AL | $13,312,227 | $1,644,964 |
Hospice Of Marshall County Foundation Inc Albertville, AL | $866,359 | $1,351,834 |
American Otological Societyresearch Foundation St Petersburg, FL | $13,191,978 | $919,211 |
Apfed Atlanta, GA | $651,819 | $642,748 |
Ucp Healthy West Orange Inc Orlando, FL | $10,767,937 | $153,098 |
Annandale Foundation Inc Suwanee, GA | $13,384,641 | $128,582 |
Sanford F And Gabrielle T Kuvin Foundation North Palm Beach, FL | $1,954,807 | $54,143 |
The Redbone Inc Islamorada, FL | $328,639 | $317,067 |
W G Raoul Foundation Orlando, FL | $3,743,044 | $286,901 |
Riding Into History Inc Jacksonville, FL | $14,982 | $0 |
Pickens County Friends Of Mental Retardation And Mental Illness Aliceville, AL | $60,393 | $59,707 |
Heart And Sole Inc Augusta, GA | $115,857 | $0 |